COLORADO ARTHRITIS CENTER, P.C.

What COLORADO ARTHRITIS CENTER, P.C. does

Colorado Arthritis Center, P.C. is a private, physician-owned rheumatology specialty practice founded in 1987 and headquartered in Englewood, Colorado. The practice provides diagnosis and treatment of autoimmune and inflammatory rheumatic diseases (rheumatoid arthritis, psoriatic arthritis, lupus, vasculitis, scleroderma, Sjogren's syndrome, myositis, antiphospholipid syndrome), non-inflammatory musculoskeletal conditions (osteoarthritis, bursitis, tendonitis, fibromyalgia, degenerative disc disease), and bone health disorders (osteoporosis and osteopenia). It operates four office locations across the Denver metropolitan area (Englewood, Littleton, Lone Tree, Thornton) staffed by six board-certified rheumatologists, several of whom hold clinical academic appointments at the University of Colorado School of Medicine.

Core service offerings include on-site infusion therapy (biologics such as Actemra, Remicade, Rituxan, Orencia, Saphnelo, Simponi Aria, Benlysta, Krystexxa), therapeutic injections (hyaluronic acid viscosupplementation, PRP, Prolia, Evenity, Zilretta, trigger point), bone density testing and osteoporosis management, and a clinical research program directed by Dr. Robert T. Spencer that provides patients access to investigative therapies. The practice does not have disclosed proprietary technology or digital products beyond a standard patient portal and online bill pay system (Liquid Payments); the offering is fundamentally physician labor plus in-office clinical infrastructure rather than a technology platform.

The business model is fee-for-service clinical care billed through commercial insurance, with copayments and outstanding balances collected at check-in. The practice declines Medicaid and Dual Complete, and charges a $50 no-show fee and a $50 late-cancellation fee. New patient acquisition is driven by physician referrals and self-scheduled appointments, supported by a marketing website, Facebook presence, and affiliations with the American College of Rheumatology, Arthritis Foundation, Lupus Foundation of Colorado, and The Myositis Association. The practice is owned and governed by its physician partners with no disclosed external private equity, strategic, or parent-company ownership.

Name

COLORADO ARTHRITIS CENTER, P.C.

Legal name

Colorado Arthritis Center P.C.

Website

https://coloradoarthritis.com

Company type

Private

Founded year

1987

Operating status

Operating

Headcount range

11–50 employees

Short description

Colorado Arthritis Center, P.C. is a physician-owned rheumatology practice founded in 1987, operating four Denver-metro clinics staffed by six board-certified rheumatologists who diagnose and treat autoimmune, inflammatory, musculoskeletal, and bone-health conditions, with on-site infusion and injection services.

Ownership category

akta.pro rank

Product category

Rheumatology Healthcare Services

NAICS

Offices of Physicians (except Mental Health Specialists) (621111)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro industry

PRIMARYHLAKAAAJ

Autoimmune/Immune Dysregulation Specialty Clinics

Healthcare & Life Sciences/Specialist Medical Practice/Allergy & Immunology

SECONDARYHLAKALAM

Pain Management (Spine & Musculoskeletal)

Healthcare & Life Sciences/Specialist Medical Practice/Orthopedics & Sports Medicine

Keywords

• Rheumatology services
• Arthritis treatment
• Autoimmune disease care
• Infusion therapy services
• Osteoporosis management

Headquarters

HQ city

Englewood

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Clinical Services Revenue: Fee-for-service medical practice revenue from patient consultations, diagnostic procedures, infusions, and injections. Revenue collected through insurance billing and patient copayments at time of service.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Colorado Arthritis Center, P.C. is a physician-owned rheumatology practice founded in 1987 that diagnoses and treats autoimmune, inflammatory, and musculoskeletal diseases including rheumatoid arthritis, psoriatic arthritis, lupus, vasculitis, scleroderma, Sjogren's, myositis, antiphospholipid syndrome, osteoarthritis, osteoporosis, bursitis, tendonitis, and fibromyalgia. Core service lines include in-office infusion therapy (biologics such as Actemra, Rituxan, Remicade, Orencia), therapeutic injections (PRP, hyaluronic acid, corticosteroid), osteoporosis management with bone density testing, and clinical research trial enrollment, delivered through four Denver metropolitan office locations.

Product overview

Colorado Arthritis Center is a rheumatology medical practice founded in 1987 that provides specialized diagnosis and treatment services for autoimmune, inflammatory, and musculoskeletal conditions. The practice operates as a unified clinical service offering infusion therapy, injection treatments, osteoporosis management, and comprehensive arthritis and autoimmune disorder care. Key services include Infusion Services (with medications like Actemra, Rituxan, Remicade) and Injection Services (including PRP, Synvisc, and other joint injections), supported by on-site bone density testing and clinical research programs. The center has multiple locations across the Denver metro area and features a team of six rheumatologists providing patient-centered care.

Differentiator

Problem solved

Functional benefit

Products and services

• Infusion Services On-site biologic infusion therapy for adults with autoimmune and inflammatory conditions. Infusible medications administered include Actemra, Avsola, Benlysta, Inflectra, Krystexxa, Orencia, Reclast, Remicade, Reneflexis, Rituxan, Ruxience, Saphnelo, Simponi Aria, Truxima, and Zolendronic Acid.
• Injection Services In-office therapeutic and joint injections for musculoskeletal care, including Boniva, Cimzia, Durolane, Evenity, Euflexxa, Hyalgan, Monovisc, Orthovisc, Platelet-Rich Plasma (PRP) injections, Prolia, Synvisc, Synvisc One, Trigger Point, and Zilretta.
• Osteoporosis Diagnosis and Management Specialized diagnosis, prevention, and treatment of osteoporosis and osteopenia, including bone density testing, dietary counseling, exercise recommendations, and medication management with bisphosphonates, denosumab, and teriparatide.
• Arthritis Treatment Specialty diagnosis and treatment of arthritis conditions including osteoarthritis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, gout, and degenerative disc disease.
• Autoimmune Disorder Treatment Specialty diagnosis and treatment of autoimmune disorders including systemic lupus erythematosus (SLE), scleroderma, Sjogren's syndrome, myositis, vasculitis, polymyalgia rheumatica, and antiphospholipid syndrome.
• Soft Tissue Condition Treatment Specialty diagnosis and treatment of non-inflammatory soft tissue conditions including bursitis, tendonitis, and fibromyalgia.
• Clinical Research Program Clinical research services providing enrolled patients access to investigational therapies and clinical research studies for new treatments of rheumatic disorders, directed by the Director of Clinical Research.

Named customers5 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators3 records

Expansion highlights5 records

Emerging players

• IVX Health: Multi-site ambulatory infusion center chain offering biologic infusions for autoimmune and rheumatologic conditions; competes for the same infusion revenue stream that underpins Colorado Arthritis Center's economics.
• Vivo Infusion: Outpatient infusion center network providing biologic and specialty infusions for autoimmune conditions; an emerging site-of-service competitor that can divert patients from independent rheumatology infusion suites.

Broad incumbents

• Cleveland Clinic Rheumatology: Major academic health system with a large rheumatology and autoimmune disease department serving as a referral destination for complex cases in Colorado's broader region.
• Hospital for Special Surgery (HSS): Nationally prominent hospital specializing in rheumatology, orthopedic, and autoimmune musculoskeletal care; a broad incumbent with rheumatology division that competes for complex autoimmune referrals.

Others

• Arthritis Foundation: National patient advocacy and research nonprofit for arthritis and related autoimmune conditions; an ecosystem partner that drives patient referrals and education but does not deliver clinical care.

Direct peers

• Rheumatic Disease Center: Independent multi-physician rheumatology specialty practice with in-office infusion services and clinical research offerings, comparable in size, scope, and operating model to Colorado Arthritis Center.
• Arthritis & Rheumatism Associates, P.C. Largest independent rheumatology specialty practice in the Washington, D.C. metro area, offering physician-led diagnosis and treatment of autoimmune, inflammatory, and musculoskeletal conditions with on-site infusion services — directly comparable business model to Colorado Arthritis Center.
• RISE (Rheumatology, Immunology, & Specialty Experts): Privately-funded multi-state rheumatology platform formed by combining several independent rheumatology groups; competes for the same physicians, infusion economics, and complex autoimmune patients as Colorado Arthritis Center.
• US Rheumatology Partners: PE-backed (Linden Capital) national platform consolidating independent rheumatology practices with infusion and clinical research programs; a leading structural competitor and potential roll-up acquirer for groups like Colorado Arthritis Center.

Regional players

• UCHealth Rheumatology: Health-system affiliated rheumatology practice operating across the Denver metro and broader Colorado — directly competes for the same patient pool, referrals from University of Colorado School of Medicine, and rheumatology specialists as Colorado Arthritis Center.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/coloradoarthritiscenter
• LinkedInlinkedin.com/company/colorado-arthritis-center-p.c.

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about COLORADO ARTHRITIS CENTER, P.C.